Moreover, the recipient mice receiving PFKFB1-overexpressing LILRB4-knockdown ARP-1 cells had enhanced growth capability compared with that of the LILRB4-knockdown ARP-1 mice, as exhibited by the increased tumor sizes and tumor weights (Fig. 4F, G). This evidence concerns the gene LILRB4 and neoplasm.